-
18 January 2022
-
This review provides insight into the effectiveness of measures implemented in the school setting to contain the COVID-19 pandemic.
While there are limitations to this review, the review demonstrates that a range of different measures can be effective at reducing COVID-19 transmission, especially when multiple interventions are implemented...
17 January 2022
-
New review from Cochrane Tobacco and Addiction Group
Key messagesHeated tobacco probably exposes people to fewer toxins than cigarettes, but possibly more than not using any tobacco. Falls in cigarette sales appeared to speed up following the launch of heated tobacco in Japan, but the authors are uncertain whether this is caused by people...
6 January 2022
-
Updated Cochrane research concludes that there is insufficient evidence for the use of Omega-3 fatty acid supplements in treating major depressive disorder.Omega-3 fatty acids are widely thought to be essential for good health and are naturally found in fatty fish such as mackerel; other seafood; and some nuts and seeds.Omega-3 fatty acids have...
7 December 2021
-
The latest update of the Cochrane review ‘Vaccines for preventing rotavirus diarrhoea: vaccines in use’ has found that rotavirus vaccines pre-qualified by the World Health Organization (WHO) (Rotarix, RotaTeq, Rotasiil, and Rotavac), prevent episodes of rotavirus diarrhoea in children and no increased risk of serious adverse events was found....
18 November 2021
-
9 November 2021
-
Cochrane Skin is pleased to announce the publication of a new review, Phototherapy for atopic eczema. This review was led by dermatologists from Amsterdam University Medical Centers, and supported by a key stakeholder: the American Academy of Dermatology (AAD). The AAD provided funding for this systematic review (32 studies, 1219 people with...
4 November 2021
-
1 November 2021
-
1 November 2021
-
1 November 2021
18 January 2022
This review provides insight into the effectiveness of measures implemented in the school setting to contain the COVID-19 pandemic. While there are limitations to this review, the review demonstrates that a range of different measures can be effective at reducing COVID-19 transmission, especially when multiple interventions are implemented...17 January 2022
New review from Cochrane Tobacco and Addiction Group Key messagesHeated tobacco probably exposes people to fewer toxins than cigarettes, but possibly more than not using any tobacco. Falls in cigarette sales appeared to speed up following the launch of heated tobacco in Japan, but the authors are uncertain whether this is caused by people...6 January 2022
Updated Cochrane research concludes that there is insufficient evidence for the use of Omega-3 fatty acid supplements in treating major depressive disorder.Omega-3 fatty acids are widely thought to be essential for good health and are naturally found in fatty fish such as mackerel; other seafood; and some nuts and seeds.Omega-3 fatty acids have...7 December 2021
The latest update of the Cochrane review ‘Vaccines for preventing rotavirus diarrhoea: vaccines in use’ has found that rotavirus vaccines pre-qualified by the World Health Organization (WHO) (Rotarix, RotaTeq, Rotasiil, and Rotavac), prevent episodes of rotavirus diarrhoea in children and no increased risk of serious adverse events was found....18 November 2021
9 November 2021
Cochrane Skin is pleased to announce the publication of a new review, Phototherapy for atopic eczema. This review was led by dermatologists from Amsterdam University Medical Centers, and supported by a key stakeholder: the American Academy of Dermatology (AAD). The AAD provided funding for this systematic review (32 studies, 1219 people with...4 November 2021
1 November 2021
1 November 2021
1 November 2021